There is much interest in developing anti-myostatin agents to reverse or prevent muscle
atrophy in adults, so it is important to characterize the effects of reducing myostatin activity …

抄録< jats: p> There is much interest in developing anti-myostatin agents to reverse or
prevent muscle atrophy in adults, so it is important to characterize the effects of reducing …

There is much interest in developing anti-myostatin agents to reverse or prevent muscle
atrophy in adults, so it is important to characterize the effects of reducing myostatin activity …

METHODS Mice with postdevelopmental knockout of floxed myostatin exon 3 (Mstnf/f), via
tamoxifen-induced Cre recombinase, have been described previously (32). Both the Mstnf/f …

There is much interest in developing anti-myostatin agents to reverse or prevent muscle
atrophy in adults, so it is important to characterize the effects of reducing myostatin activity …

There is much interest in developing anti-myostatin agents to reverse or prevent muscle
atrophy in adults, so it is important to characterize the effects of reducing myostatin activity …

There is much interest in developing anti-myostatin agents to reverse or prevent muscle 23
atrophy in adults, so it is important to characterize the effects of reducing myostatin activity …

METHODS Mice with postdevelopmental knockout of floxed myostatin exon 3 (Mstnf/f), via
tamoxifen-induced Cre recombinase, have been described previously (32). Both the Mstnf/f …

There is much interest in developing anti-myostatin agents to reverse or prevent muscle
atrophy in adults, so it is important to characterize the effects of reducing myostatin activity …